{"transactions":[{"id":724501,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T01:30:08.000Z","date":"2026-06-25","kind":"exercise","planned":false,"acquired":false,"shares":24100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":31261,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":24100},"source":{"system":"sec-edgar","filing":"0001593086-26-000012","document":"form4-06292026_090604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000012/form4-06292026_090604.xml","form_type":"4"}},{"id":724500,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-30T01:30:08.000Z","date":"2026-06-25","kind":"sale","planned":false,"acquired":false,"shares":24100,"price":30.38,"value":732158.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive."}],"balance_after":30547,"source":{"system":"sec-edgar","filing":"0001593086-26-000012","document":"form4-06292026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000012/form4-06292026_090604.xml","form_type":"4"}},{"id":724499,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-30T01:30:08.000Z","date":"2026-06-25","kind":"exercise","planned":false,"acquired":true,"shares":24100,"price":3.18,"value":76638.0,"ownership":{"direct":true},"balance_after":54647,"source":{"system":"sec-edgar","filing":"0001593086-26-000012","document":"form4-06292026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000012/form4-06292026_090604.xml","form_type":"4"}},{"id":724498,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T01:30:06.000Z","date":"2026-06-25","kind":"exercise","planned":false,"acquired":false,"shares":24100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":91980,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":24100},"source":{"system":"sec-edgar","filing":"0001593087-26-000013","document":"form4-06292026_090601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000013/form4-06292026_090601.xml","form_type":"4"}},{"id":724497,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-30T01:30:06.000Z","date":"2026-06-25","kind":"sale","planned":false,"acquired":false,"shares":24100,"price":30.38,"value":732158.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive."}],"balance_after":11223,"source":{"system":"sec-edgar","filing":"0001593087-26-000013","document":"form4-06292026_090601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000013/form4-06292026_090601.xml","form_type":"4"}},{"id":724496,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-30T01:30:06.000Z","date":"2026-06-25","kind":"exercise","planned":false,"acquired":true,"shares":24100,"price":3.18,"value":76638.0,"ownership":{"direct":true},"balance_after":35323,"source":{"system":"sec-edgar","filing":"0001593087-26-000013","document":"form4-06292026_090601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000013/form4-06292026_090601.xml","form_type":"4"}},{"id":728008,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T00:00:09.000Z","date":"2026-06-24","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":55361,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001593086-26-000010","document":"form4-06242026_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000010/form4-06242026_080605.xml","form_type":"4"}},{"id":728007,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T00:00:09.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":55761,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001593086-26-000010","document":"form4-06242026_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000010/form4-06242026_080605.xml","form_type":"4"}},{"id":728006,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:09.000Z","date":"2026-06-24","kind":"sale","planned":false,"acquired":false,"shares":400,"price":30,"value":12000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":30547,"source":{"system":"sec-edgar","filing":"0001593086-26-000010","document":"form4-06242026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000010/form4-06242026_080605.xml","form_type":"4"}},{"id":728005,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:09.000Z","date":"2026-06-24","kind":"exercise","planned":false,"acquired":true,"shares":400,"price":3.18,"value":1272.0,"ownership":{"direct":true},"balance_after":30947,"source":{"system":"sec-edgar","filing":"0001593086-26-000010","document":"form4-06242026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000010/form4-06242026_080605.xml","form_type":"4"}},{"id":728004,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:09.000Z","date":"2026-06-22","kind":"sale","planned":false,"acquired":false,"shares":500,"price":30,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":30547,"source":{"system":"sec-edgar","filing":"0001593086-26-000010","document":"form4-06242026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000010/form4-06242026_080605.xml","form_type":"4"}},{"id":728003,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:09.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":3.18,"value":1590.0,"ownership":{"direct":true},"balance_after":31047,"source":{"system":"sec-edgar","filing":"0001593086-26-000010","document":"form4-06242026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000010/form4-06242026_080605.xml","form_type":"4"}},{"id":728002,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T00:00:07.000Z","date":"2026-06-24","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":116080,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001593087-26-000011","document":"form4-06242026_080603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000011/form4-06242026_080603.xml","form_type":"4"}},{"id":728001,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T00:00:07.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":116480,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001593087-26-000011","document":"form4-06242026_080603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000011/form4-06242026_080603.xml","form_type":"4"}},{"id":728000,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:07.000Z","date":"2026-06-24","kind":"sale","planned":false,"acquired":false,"shares":400,"price":30,"value":12000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":11223,"source":{"system":"sec-edgar","filing":"0001593087-26-000011","document":"form4-06242026_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000011/form4-06242026_080603.xml","form_type":"4"}},{"id":727999,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:07.000Z","date":"2026-06-24","kind":"exercise","planned":false,"acquired":true,"shares":400,"price":3.18,"value":1272.0,"ownership":{"direct":true},"balance_after":11623,"source":{"system":"sec-edgar","filing":"0001593087-26-000011","document":"form4-06242026_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000011/form4-06242026_080603.xml","form_type":"4"}},{"id":727998,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:07.000Z","date":"2026-06-22","kind":"sale","planned":false,"acquired":false,"shares":500,"price":30,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":11223,"source":{"system":"sec-edgar","filing":"0001593087-26-000011","document":"form4-06242026_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000011/form4-06242026_080603.xml","form_type":"4"}},{"id":727997,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-25T00:00:07.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":3.18,"value":1590.0,"ownership":{"direct":true},"balance_after":11723,"source":{"system":"sec-edgar","filing":"0001593087-26-000011","document":"form4-06242026_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000011/form4-06242026_080603.xml","form_type":"4"}},{"id":760547,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":43586,"kind":"person","name":"Maurer Michael T","position":1,"cik":"0002137554","reported_name":"Maurer Michael T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T01:55:07.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 25% on the first anniversary of the first day of the month following the Grant Date, with the remainder to vest at the rate of 1/36 per month thereafter. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":80000,"derivative":{"exercise_price":29.36,"expiration_date":"2036-05-26","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0002137554-26-000006","document":"form4-05282026_090501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000213755426000006/form4-05282026_090501.xml","form_type":"4"}},{"id":772800,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T20:15:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing as of July 1, 2016."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001593087-26-000009","document":"form4-05192026_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000009/form4-05192026_040501.xml","form_type":"4"}},{"id":772799,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-19T20:15:07.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":1.39,"value":4170.0,"ownership":{"direct":true},"balance_after":11223,"source":{"system":"sec-edgar","filing":"0001593087-26-000009","document":"form4-05192026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000009/form4-05192026_040501.xml","form_type":"4"}},{"id":779613,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":47414,"kind":"person","name":"Litvack Frank","position":1,"cik":"0001310715","reported_name":"Litvack Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T21:00:05.000Z","date":"2026-05-13","kind":"exercise","planned":false,"acquired":false,"shares":3937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was granted on June 2, 2016 and was previously reported as covering 39,375 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1,750 shares vested immediately on June 2, 2016. The remaining shares vested on December 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":3937},"source":{"system":"sec-edgar","filing":"0001310715-26-000004","document":"form4-05142026_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000131071526000004/form4-05142026_050501.xml","form_type":"4"}},{"id":779612,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":47414,"kind":"person","name":"Litvack Frank","position":1,"cik":"0001310715","reported_name":"Litvack Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T21:00:05.000Z","date":"2026-05-13","kind":"exercise","planned":false,"acquired":true,"shares":3937,"price":1.39,"value":5472.43,"ownership":{"direct":true},"balance_after":133776,"source":{"system":"sec-edgar","filing":"0001310715-26-000004","document":"form4-05142026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000131071526000004/form4-05142026_050501.xml","form_type":"4"}},{"id":794279,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:30:08.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":56261,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593086-26-000008","document":"form4-05042026_040503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000008/form4-05042026_040503.xml","form_type":"4"}},{"id":794278,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-05-04T20:30:08.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":31.7019,"value":792547.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.88 to $33.19, inclusive."}],"balance_after":30547,"source":{"system":"sec-edgar","filing":"0001593086-26-000008","document":"form4-05042026_040503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000008/form4-05042026_040503.xml","form_type":"4"}},{"id":794277,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-05-04T20:30:08.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":3.18,"value":79500.0,"ownership":{"direct":true},"balance_after":55547,"source":{"system":"sec-edgar","filing":"0001593086-26-000008","document":"form4-05042026_040503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000008/form4-05042026_040503.xml","form_type":"4"}},{"id":794276,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:30:07.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":116980,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593087-26-000007","document":"form4-05042026_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000007/form4-05042026_040501.xml","form_type":"4"}},{"id":794275,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-04T20:30:07.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":31.7016,"value":792540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.89 to $33.19, inclusive."}],"balance_after":8223,"source":{"system":"sec-edgar","filing":"0001593087-26-000007","document":"form4-05042026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000007/form4-05042026_040501.xml","form_type":"4"}},{"id":794274,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-04T20:30:07.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":3.18,"value":79500.0,"ownership":{"direct":true},"balance_after":33223,"source":{"system":"sec-edgar","filing":"0001593087-26-000007","document":"form4-05042026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000007/form4-05042026_040501.xml","form_type":"4"}},{"id":817326,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T21:00:07.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":false,"shares":7529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":161,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":7529},"source":{"system":"sec-edgar","filing":"0001873796-26-000006","document":"form4-04032026_050401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000006/form4-04032026_050401.xml","form_type":"4"}},{"id":817325,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T21:00:07.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":7529,"price":32,"value":240928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001873796-26-000006","document":"form4-04032026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000006/form4-04032026_050401.xml","form_type":"4"}},{"id":817324,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T21:00:07.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":7529,"price":3.18,"value":23942.22,"ownership":{"direct":true},"balance_after":7529,"source":{"system":"sec-edgar","filing":"0001873796-26-000006","document":"form4-04032026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000006/form4-04032026_050401.xml","form_type":"4"}},{"id":823279,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:15.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":2819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":81261,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":2819},"source":{"system":"sec-edgar","filing":"0001593086-26-000006","document":"form4-04012026_080410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000006/form4-04012026_080410.xml","form_type":"4"}},{"id":823278,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:15.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":21488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2021."}],"balance_after":74205,"derivative":{"exercise_price":3.74,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":21488},"source":{"system":"sec-edgar","filing":"0001593086-26-000006","document":"form4-04012026_080410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000006/form4-04012026_080410.xml","form_type":"4"}},{"id":823277,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:15.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"shares","element":"transactionShares","label":"F3","text":"This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2018."}],"balance_after":2807,"derivative":{"exercise_price":1.39,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":693},"source":{"system":"sec-edgar","filing":"0001593086-26-000006","document":"form4-04012026_080410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000006/form4-04012026_080410.xml","form_type":"4"}},{"id":823276,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-04-02T00:00:15.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":30.1174,"value":752935.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.31, inclusive."}],"balance_after":30547,"source":{"system":"sec-edgar","filing":"0001593086-26-000006","document":"form4-04012026_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000006/form4-04012026_080410.xml","form_type":"4"}},{"id":823275,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-04-02T00:00:15.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":2819,"price":3.18,"value":8964.42,"ownership":{"direct":true},"balance_after":55547,"source":{"system":"sec-edgar","filing":"0001593086-26-000006","document":"form4-04012026_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000006/form4-04012026_080410.xml","form_type":"4"}},{"id":823274,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-04-02T00:00:15.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":21488,"price":3.74,"value":80365.12,"ownership":{"direct":true},"balance_after":52728,"source":{"system":"sec-edgar","filing":"0001593086-26-000006","document":"form4-04012026_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000006/form4-04012026_080410.xml","form_type":"4"}},{"id":823273,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-04-02T00:00:15.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":693,"price":1.39,"value":963.27,"ownership":{"direct":true},"balance_after":31240,"source":{"system":"sec-edgar","filing":"0001593086-26-000006","document":"form4-04012026_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000006/form4-04012026_080410.xml","form_type":"4"}},{"id":823272,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:12.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":53735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.86,"expiration_date":"2031-07-23","underlying":"Common Stock","underlying_shares":53735},"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823271,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:12.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":61265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022."}],"balance_after":53735,"derivative":{"exercise_price":4.86,"expiration_date":"2031-07-23","underlying":"Common Stock","underlying_shares":61265},"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823270,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":53735,"price":31.0268,"value":1667225.098,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.39, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823269,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":53735,"price":4.86,"value":261152.1,"ownership":{"direct":true},"balance_after":53735,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823268,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":61265,"price":30.168,"value":1848242.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823267,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":61265,"price":4.86,"value":297747.9,"ownership":{"direct":true},"balance_after":61265,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823266,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:11.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":141980,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593087-26-000005","document":"form4-04012026_080406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000005/form4-04012026_080406.xml","form_type":"4"}},{"id":823265,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-02T00:00:11.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":30.1261,"value":753152.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.32, inclusive."}],"balance_after":8223,"source":{"system":"sec-edgar","filing":"0001593087-26-000005","document":"form4-04012026_080406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000005/form4-04012026_080406.xml","form_type":"4"}},{"id":823264,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-02T00:00:11.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":3.18,"value":79500.0,"ownership":{"direct":true},"balance_after":33223,"source":{"system":"sec-edgar","filing":"0001593087-26-000005","document":"form4-04012026_080406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000005/form4-04012026_080406.xml","form_type":"4"}},{"id":826677,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-27T23:15:05.000Z","date":"2025-12-30","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option was granted on January 3, 2017 and was previously covering 25,000 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on January 3, 2017 and was previously covering 25,000 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001593086-26-000004","document":"form4-03272026_070301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000004/form4-03272026_070301.xml","form_type":"4"}},{"id":826676,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-03-27T23:15:05.000Z","date":"2025-12-30","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":1.39,"value":3475.0,"ownership":{"direct":true},"balance_after":30547,"source":{"system":"sec-edgar","filing":"0001593086-26-000004","document":"form4-03272026_070301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000004/form4-03272026_070301.xml","form_type":"4"}},{"id":944988,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-07T21:45:28.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, upon vesting, one share of the Issuer's common stock in accordance with the Issuer's 2025 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on January 5, 2026 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on January 5, 2026 vest annually at a rate of 25% commencing on February 1, 2027. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on January 5, 2026 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on January 5, 2026 vest annually at a rate of 25% commencing on February 1, 2027. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001593084-26-000002","document":"form4-01072026_040125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308426000002/form4-01072026_040125.xml","form_type":"4"}},{"id":944987,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:28.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of the award vest and become exercisable on the date of U.S. Food and Drug Administration approval of Deramiocel. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":100000,"derivative":{"exercise_price":24.81,"expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001593084-26-000002","document":"form4-01072026_040125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308426000002/form4-01072026_040125.xml","form_type":"4"}},{"id":944986,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:28.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2026, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the\nIssuer terminates prior to vesting."}],"balance_after":50000,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001593084-26-000002","document":"form4-01072026_040125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308426000002/form4-01072026_040125.xml","form_type":"4"}},{"id":944985,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-07T21:45:26.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, upon vesting, one share of the Issuer's common stock in accordance with the Issuer's 2025 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on January 5, 2026 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on January 5, 2026 vest annually at a rate of 25% commencing on February 1, 2027. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on January 5, 2026 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on January 5, 2026 vest annually at a rate of 25% commencing on February 1, 2027. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001593087-26-000002","document":"form4-01072026_040123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000002/form4-01072026_040123.xml","form_type":"4"}},{"id":944984,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:26.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of the award vest and become exercisable on the date of U.S. Food and Drug Administration approval of Deramiocel. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":24.81,"expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593087-26-000002","document":"form4-01072026_040123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000002/form4-01072026_040123.xml","form_type":"4"}},{"id":944983,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:26.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2026, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":25000,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593087-26-000002","document":"form4-01072026_040123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308726000002/form4-01072026_040123.xml","form_type":"4"}},{"id":944982,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:24.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of the award vest and become exercisable on the date of U.S. Food and Drug Administration approval of Deramiocel. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":24.81,"expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001593086-26-000002","document":"form4-01072026_040121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000002/form4-01072026_040121.xml","form_type":"4"}},{"id":944981,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:24.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2026, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":22500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001593086-26-000002","document":"form4-01072026_040121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000159308626000002/form4-01072026_040121.xml","form_type":"4"}},{"id":944980,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69870,"kind":"person","name":"Auwaerter Paul Gisbert","position":1,"cik":"0001982730","reported_name":"Auwaerter Paul Gisbert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:23.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":5420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 5, 2026, the date of the grant. The award pertains to annual board service."}],"balance_after":5420,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":5420},"source":{"system":"sec-edgar","filing":"0001982730-26-000002","document":"form4-01072026_040119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000198273026000002/form4-01072026_040119.xml","form_type":"4"}},{"id":944979,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69870,"kind":"person","name":"Auwaerter Paul Gisbert","position":1,"cik":"0001982730","reported_name":"Auwaerter Paul Gisbert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:23.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":1360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 5, 2026, the date of the grant. The award pertains to annual board committee service."}],"balance_after":1360,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":1360},"source":{"system":"sec-edgar","filing":"0001982730-26-000002","document":"form4-01072026_040119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000198273026000002/form4-01072026_040119.xml","form_type":"4"}},{"id":944978,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69870,"kind":"person","name":"Auwaerter Paul Gisbert","position":1,"cik":"0001982730","reported_name":"Auwaerter Paul Gisbert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:23.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001982730-26-000002","document":"form4-01072026_040119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000198273026000002/form4-01072026_040119.xml","form_type":"4"}},{"id":944977,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":19877,"kind":"person","name":"Kelliher Mike","position":1,"cik":"0001987188","reported_name":"Kelliher Mike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:21.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001987188-26-000002","document":"form4-01072026_040117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000198718826000002/form4-01072026_040117.xml","form_type":"4"}},{"id":944976,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":36659,"kind":"person","name":"Gotwals Philip J","position":1,"cik":"0001982655","reported_name":"Gotwals Philip J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:19.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001982655-26-000002","document":"form4-01072026_040115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000198265526000002/form4-01072026_040115.xml","form_type":"4"}},{"id":944975,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:17.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001873796-26-000002","document":"form4-01072026_040113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000002/form4-01072026_040113.xml","form_type":"4"}},{"id":944974,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:14.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001310611-26-000002","document":"form4-01072026_040111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000131061126000002/form4-01072026_040111.xml","form_type":"4"}},{"id":944973,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69868,"kind":"person","name":"DUNBAR GEORGE W JR","position":1,"cik":"0001194712","reported_name":"DUNBAR GEORGE W JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:12.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001194712-26-000002","document":"form4-01072026_040103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000119471226000002/form4-01072026_040103.xml","form_type":"4"}},{"id":944969,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":47414,"kind":"person","name":"Litvack Frank","position":1,"cik":"0001310715","reported_name":"Litvack Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:05.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service as Executive Chairman. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":50000,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001310715-26-000002","document":"form4-01072026_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000131071526000002/form4-01072026_040101.xml","form_type":"4"}},{"id":959966,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69868,"kind":"person","name":"DUNBAR GEORGE W JR","position":1,"cik":"0001194712","reported_name":"DUNBAR GEORGE W JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-23T19:55:05.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares were fully vested and exercisable as of December 31, 2016."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194712-25-000004","document":"form4-12232025_021201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000119471225000004/form4-12232025_021201.xml","form_type":"4"}},{"id":959965,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69868,"kind":"person","name":"DUNBAR GEORGE W JR","position":1,"cik":"0001194712","reported_name":"DUNBAR GEORGE W JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T19:55:05.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":1.39,"value":4170.0,"ownership":{"direct":true},"balance_after":14306,"source":{"system":"sec-edgar","filing":"0001194712-25-000004","document":"form4-12232025_021201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000119471225000004/form4-12232025_021201.xml","form_type":"4"}},{"id":1223488,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T22:00:13.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was granted on March 3, 2015 and was previously covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested 1/48th on the first day of each month commencing April 1, 2015."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was granted on March 3, 2015 and was previously covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-006986","document":"form4-03052025_050301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006986/form4-03052025_050301.xml","form_type":"4"}},{"id":1223487,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T22:00:13.000Z","date":"2025-03-05","kind":"other","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transferred to reporting person's ex-spouse pursuant to settlement in divorce proceeding."}],"balance_after":211104,"source":{"system":"sec-edgar","filing":"0001415889-25-006986","document":"form4-03052025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006986/form4-03052025_050301.xml","form_type":"4"}},{"id":1223486,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T22:00:13.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":1.39,"value":34750.0,"ownership":{"direct":true},"balance_after":223604,"source":{"system":"sec-edgar","filing":"0001415889-25-006986","document":"form4-03052025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006986/form4-03052025_050301.xml","form_type":"4"}},{"id":1230755,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:00:17.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 25,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing April 1, 2015."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 25,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001415889-25-006734","document":"form4-03042025_070301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006734/form4-03042025_070301.xml","form_type":"4"}},{"id":1230754,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T00:00:17.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":1.39,"value":3475.0,"ownership":{"direct":true},"balance_after":8223,"source":{"system":"sec-edgar","filing":"0001415889-25-006734","document":"form4-03042025_070301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006734/form4-03042025_070301.xml","form_type":"4"}},{"id":1230753,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":47414,"kind":"person","name":"Litvack Frank","position":1,"cik":"0001310715","reported_name":"Litvack Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:00:13.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on March 3, 2015 and was previously reported as covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested 1/48th on the first day of each month commencing April 1, 2015."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This option was granted on March 3, 2015 and was previously reported as covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-006736","document":"form4-03042025_070305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006736/form4-03042025_070305.xml","form_type":"4"}},{"id":1230752,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":47414,"kind":"person","name":"Litvack Frank","position":1,"cik":"0001310715","reported_name":"Litvack Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T00:00:13.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2543,"price":13.67,"value":34762.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 3, 2025 of $13.67. The options would otherwise expire on March 3, 2025, pursuant to their terms."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 3, 2025 of $13.67. The options would otherwise expire on March 3, 2025, pursuant to their terms."}],"balance_after":129839,"source":{"system":"sec-edgar","filing":"0001415889-25-006736","document":"form4-03042025_070305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006736/form4-03042025_070305.xml","form_type":"4"}},{"id":1230751,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":47414,"kind":"person","name":"Litvack Frank","position":1,"cik":"0001310715","reported_name":"Litvack Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T00:00:13.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":1.39,"value":34750.0,"ownership":{"direct":true},"balance_after":132382,"source":{"system":"sec-edgar","filing":"0001415889-25-006736","document":"form4-03042025_070305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006736/form4-03042025_070305.xml","form_type":"4"}},{"id":1230750,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69868,"kind":"person","name":"DUNBAR GEORGE W JR","position":1,"cik":"0001194712","reported_name":"DUNBAR GEORGE W JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:00:07.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 7,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares were fully vested and exercisable as of March 3, 2015, the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 7,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-25-006735","document":"form4-03042025_070303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006735/form4-03042025_070303.xml","form_type":"4"}},{"id":1230749,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69868,"kind":"person","name":"DUNBAR GEORGE W JR","position":1,"cik":"0001194712","reported_name":"DUNBAR GEORGE W JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T00:00:07.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":750,"price":1.39,"value":1042.5,"ownership":{"direct":true},"balance_after":11306,"source":{"system":"sec-edgar","filing":"0001415889-25-006735","document":"form4-03042025_070303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006735/form4-03042025_070303.xml","form_type":"4"}},{"id":1238979,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-01T00:30:06.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 7,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares were fully vested and exercisable as of March 3, 2015, the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on March 3, 2015 and was previously reported as covering 7,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-25-006069","document":"form4-02282025_070201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006069/form4-02282025_070201.xml","form_type":"4"}},{"id":1238978,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":82699,"kind":"person","name":"COLLIER EARL M JR","position":1,"cik":"0001201254","reported_name":"COLLIER EARL M JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-01T00:30:06.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":750,"price":1.39,"value":1042.5,"ownership":{"direct":true},"balance_after":57606,"source":{"system":"sec-edgar","filing":"0001415889-25-006069","document":"form4-02282025_070201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925006069/form4-02282025_070201.xml","form_type":"4"}},{"id":1311446,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":47414,"kind":"person","name":"Litvack Frank","position":1,"cik":"0001310715","reported_name":"Litvack Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:32:13.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service as Executive Chairman. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":50000,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-000932","document":"form4-01072025_120110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000932/form4-01072025_120110.xml","form_type":"4"}},{"id":1311444,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:27.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant."}],"balance_after":6170,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":6170},"source":{"system":"sec-edgar","filing":"0001415889-25-000876","document":"form4-01062025_070123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000876/form4-01062025_070123.xml","form_type":"4"}},{"id":1311443,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:27.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2025, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":75000,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-25-000876","document":"form4-01062025_070123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000876/form4-01062025_070123.xml","form_type":"4"}},{"id":1311442,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34921,"kind":"person","name":"Bergmann Anthony","position":1,"cik":"0001593087","reported_name":"Bergmann Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T00:00:27.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":3342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents fully vested Restricted Stock Units as of January 2, 2025 issued for services with the Company."}],"balance_after":5723,"source":{"system":"sec-edgar","filing":"0001415889-25-000876","document":"form4-01062025_070123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000876/form4-01062025_070123.xml","form_type":"4"}},{"id":1311441,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":34922,"kind":"person","name":"Krasney Karen","position":1,"cik":"0001593086","reported_name":"Krasney Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:24.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2025, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":60000,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-25-000875","document":"form4-01062025_070120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000875/form4-01062025_070120.xml","form_type":"4"}},{"id":1311440,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:21.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":34962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant."}],"balance_after":34962,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":34962},"source":{"system":"sec-edgar","filing":"0001415889-25-000874","document":"form4-01062025_070118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000874/form4-01062025_070118.xml","form_type":"4"}},{"id":1311439,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69871,"kind":"person","name":"Marban Linda","position":1,"cik":"0001593084","reported_name":"Marban Linda","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:21.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2025, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":210000,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001415889-25-000874","document":"form4-01062025_070118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000874/form4-01062025_070118.xml","form_type":"4"}},{"id":1311438,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":19877,"kind":"person","name":"Kelliher Mike","position":1,"cik":"0001987188","reported_name":"Kelliher Mike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:19.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service."}],"balance_after":5750,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-000873","document":"form4-01062025_070115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000873/form4-01062025_070115.xml","form_type":"4"}},{"id":1311437,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":19877,"kind":"person","name":"Kelliher Mike","position":1,"cik":"0001987188","reported_name":"Kelliher Mike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:19.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service."}],"balance_after":1440,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":1440},"source":{"system":"sec-edgar","filing":"0001415889-25-000873","document":"form4-01062025_070115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000873/form4-01062025_070115.xml","form_type":"4"}},{"id":1311436,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":19877,"kind":"person","name":"Kelliher Mike","position":1,"cik":"0001987188","reported_name":"Kelliher Mike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:19.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":11940,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001415889-25-000873","document":"form4-01062025_070115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000873/form4-01062025_070115.xml","form_type":"4"}},{"id":1311435,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69870,"kind":"person","name":"Auwaerter Paul Gisbert","position":1,"cik":"0001982730","reported_name":"Auwaerter Paul Gisbert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:17.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service."}],"balance_after":5750,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-000872","document":"form4-01062025_070113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000872/form4-01062025_070113.xml","form_type":"4"}},{"id":1311434,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69870,"kind":"person","name":"Auwaerter Paul Gisbert","position":1,"cik":"0001982730","reported_name":"Auwaerter Paul Gisbert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:17.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service."}],"balance_after":1440,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":1440},"source":{"system":"sec-edgar","filing":"0001415889-25-000872","document":"form4-01062025_070113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000872/form4-01062025_070113.xml","form_type":"4"}},{"id":1311433,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69870,"kind":"person","name":"Auwaerter Paul Gisbert","position":1,"cik":"0001982730","reported_name":"Auwaerter Paul Gisbert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:17.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":11940,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001415889-25-000872","document":"form4-01062025_070113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000872/form4-01062025_070113.xml","form_type":"4"}},{"id":1311432,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service."}],"balance_after":5750,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-000871","document":"form4-01062025_070111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000871/form4-01062025_070111.xml","form_type":"4"}},{"id":1311431,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":2520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service."}],"balance_after":2520,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2520},"source":{"system":"sec-edgar","filing":"0001415889-25-000871","document":"form4-01062025_070111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000871/form4-01062025_070111.xml","form_type":"4"}},{"id":1311430,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":11940,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001415889-25-000871","document":"form4-01062025_070111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000871/form4-01062025_070111.xml","form_type":"4"}},{"id":1311429,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service."}],"balance_after":5750,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-000870","document":"form4-01062025_070109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000870/form4-01062025_070109.xml","form_type":"4"}},{"id":1311428,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service."}],"balance_after":6480,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":6480},"source":{"system":"sec-edgar","filing":"0001415889-25-000870","document":"form4-01062025_070109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000870/form4-01062025_070109.xml","form_type":"4"}},{"id":1311427,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":11940,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001415889-25-000870","document":"form4-01062025_070109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000870/form4-01062025_070109.xml","form_type":"4"}}],"next_cursor":"2025-01-07T00:00:14.000000Z,1311427"}